Use of praziquantel as an adjuvant enhances protection and Tc-17 responses to killed H5N1 virus vaccine in mice.
第一作者:
Qiang,Zou
第一单位:
Key Laboratory of Medical Molecular Virology of MOH and MOE, Fudan University Shanghai Medical College, Shanghai, China.
作者:
医学主题词
佐剂, 免疫(Adjuvants, Immunologic);动物(Animals);细胞因子类(Cytokines);细胞毒性, 免疫(Cytotoxicity, Immunologic);女(雌)性(Female);人类(Humans);流感病毒A型, H5N1亚型(Influenza A Virus, H5N1 Subtype);流感疫苗(Influenza Vaccines);淋巴细胞活化(Lymphocyte Activation);小鼠(Mice);小鼠, 近交C57BL(Mice, Inbred C57BL);小鼠, 基因敲除(Mice, Knockout);正黏病毒科感染(Orthomyxoviridae Infections);吡喹酮(Praziquantel);T淋巴细胞, 细胞毒性(T-Lymphocytes, Cytotoxic);疫苗, 灭活(Vaccines, Inactivated)
DOI
10.1371/journal.pone.0034865
PMID
22529945
发布时间
2021-10-21
- 浏览1
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



